Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2010
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101898970A N-monosubstituted trans-1,2-diaminocyclohexane derivatives and preparation method thereof
12/01/2010CN101671298B Synthesis method of 2-chloronicotinoyl chloride
12/01/2010CN101391978B Novel synthetic method of HIV-1 protease inhibitor atazanavir
12/01/2010CN101337923B Process for purifying crude pyridine
12/01/2010CN101314588B Preparation for 6-chlorine-2-trichloromethyl pyridine
12/01/2010CN101240168B Blue light organic luminescent material and preparation method thereof
12/01/2010CN101161343B A novel catalyst for synthesizing pyridine base as well as its preparing and using method
12/01/2010CN101121694B Water gelling agent used for forming supermolecule hydrogel and preparation method thereof
12/01/2010CN101056857B Process for preparation of isonicotinic acid derivatives
11/2010
11/30/2010US7842825 Using 3-(3-chlorobiphenyl-4-oxymethyl)benzoic acid; antidiabetic agents; type 2 diabetes; insulin resistance; impaired glucose tolerance
11/30/2010US7842705 Curcumin analogs with anti-tumor and anti-angiogenic properties
11/30/2010CA2583492C Naphthalene and isoquinoline derivatives bearing a pyridyl group for the treatment of skin lesions
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2460682C Ester compound and medical use thereof
11/30/2010CA2450076C Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010135579A1 Fluorinated diaryl urea derivatives
11/25/2010WO2010134193A1 Method for producing pyridine compound and pyridine compound
11/25/2010WO2010134014A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010WO2010133973A1 1,4 dihydropyridine derivatives and their uses
11/25/2010WO2010133748A1 Protease inhibitors
11/25/2010WO2010133312A1 Halogen-substituted compounds as pesticides
11/25/2010WO2010133232A1 Novel herbicides
11/25/2010WO2010132992A1 Compounds for the inhibition of herpesviruses
11/25/2010WO2009141290A9 Substituted pyridin-4-ylmethyl sulfonamides
11/25/2010US20100298572 Methods of preparing secondary carbinamine compounds with boronic acids
11/25/2010US20100298571 Arylamine synthesis method
11/25/2010US20100298385 Protein kinase inhibitors useful for treatment of cancers
11/25/2010US20100298374 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010US20100298367 Conformationally Constrained Carboxylic Acid Derivatives Useful for Treating Metabolic Disorders
11/25/2010US20100298336 Pyrimidines as novel therapeutic agents
11/25/2010US20100298325 Pyridine derivatives for the treatment of amyloid-related diseases
11/25/2010US20100298308 Compositions and methods for bone formation and remodeling
11/25/2010US20100298284 Benzamides and related inhibitors of factor xa
11/25/2010US20100298270 Novel Compounds and Methods of Using Them
11/25/2010US20100298221 2-phenoxy nicotine acid derivative and use thereof
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100298138 Aminoazoline and Urea Derivatives for Combating Animal Pests
11/25/2010US20100298122 Polymerisation of Ethylene and Alpha Olefins with Single Site Catalysts having an Anionic Scorpion-Like Ligand
11/25/2010US20100297181 AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ
11/25/2010US20100297077 Novel aryl potassium channel blockers and uses thereof
11/25/2010US20100297016 Quarternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
11/25/2010CA2762805A1 1,4-dihydropyridine derivatives and their uses
11/25/2010CA2762427A1 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010CA2761685A1 Novel herbicides
11/25/2010CA2760885A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010CA2758222A1 Protease inhibitors
11/24/2010EP2253618A1 Compound having 6-membered aromatic ring
11/24/2010EP2253617A1 Halogenated compounds as pesticides
11/24/2010EP2253616A1 Process for the preparation of compounds capable of activating cholinergic receptors
11/24/2010EP2253610A1 Method for manufacturing 4-aminobut-2-enolids
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252588A2 Process for preparing pyridone derivatives
11/24/2010EP1940813B1 Heterocyclic amide derivatives useful as microbiocides
11/24/2010EP1599466B1 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010EP1572651B1 Compounds useful as pesticides
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN101896461A Gamma secretase modulators
11/24/2010CN101896452A Carbon linked modulators of gamma-secretase
11/24/2010CN101891679A Preparation method of pyridinedicarboxylic acid and diaminopyridine proton transfer compound
11/24/2010CN101891678A 4-(N,N-dimethyl) aminopyridine derivate and synthesis method thereof
11/24/2010CN101891677A Preparation method of 6-methyl-2-ethyl-3-hydroxy pyridine
11/24/2010CN101891676A Novel method for preparing 5-methyl-1-phenyl-2-(1H)-pyridone
11/24/2010CN101891675A Production method of 6-chloro-2-(trichloromethyl)pyridine
11/24/2010CN101891674A 4-styryl pyridine compound and preparation method as well as application thereof
11/24/2010CN101891673A Organic material and application thereof in organic electroluminescence devices
11/24/2010CN101891643A Method for catalytic preparation of amide and derivatives thereof in aqueous phase
11/24/2010CN101891572A Synthesis method for novel chiral asymmetric secondary amine belonging to N-substituted amino acid esters
11/24/2010CN101890366A Cupric salt-containing catalyst system and application thereof
11/24/2010CN101129365B Analgesics use of ricinine
11/24/2010CN101065368B Substituted oxyguanidines
11/24/2010CN101003508B Electron transport compound and organic light emitting device comprising the same
11/23/2010US7838679 Pyridinium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
11/23/2010US7838678 Process for preparing atazanavir bisulfate and novel forms
11/23/2010US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
11/23/2010US7838554 dyslipidemia; regulating lipid, lipoprotein, insulin, glucose levels in the blood; 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid; 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol; 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; 2,2,14,14-Tetramethyl-pentadecane-1,6,10,15-tetraol
11/23/2010US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
11/23/2010US7838540 3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010US7838299 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/23/2010CA2342200C Use of certain drugs for treating nerve root injury
11/23/2010CA2319836C Hydroxylation activated prodrugs
11/18/2010WO2010132663A1 Pegylated azapeptide derivatives as hiv protease inhibitors
11/18/2010WO2010132016A1 Bis-(sulfonylamino) derivatives for treatment of pain and inflammation
11/18/2010WO2010131717A1 Prion protein structure transformation inhibitor and utilization of same
11/18/2010WO2010131147A1 Cyclobutenedione derivatives
11/18/2010WO2010131146A1 Cyclobutenedione derivatives
11/18/2010WO2010131145A1 Cyclobutenedione derivatives
11/18/2010WO2010131030A1 Pyridylurea derivatives and their therapeutic use
11/18/2010WO2010130796A1 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010WO2010130638A1 Sulfonamide compounds, pharmaceutical compositions and uses thereof
11/18/2010WO2010130385A1 Monoazo compounds
11/18/2010WO2010130384A1 Bisazo compounds
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 633